Moderna Inc. said its US Covid business did better than expected last year, a rare bright spot for the vaccine maker, which has struggled with the decline of people getting its shot.
Moderna Inc. said its US Covid business did better than expected last year, a rare bright spot for the vaccine maker, which has struggled with the decline of people getting its shot.
The number of people in the US getting Covid shots fell 26% in 2025… [300 chars]
Source: Bloomberg | Published: 2026-01-12T12:00:00Z
Credit: Bloomberg
